Downtrend on the daily chart: below its 50- and 200-day averages · 50-day below the 200-day · SuperTrend up since Oct 9 · below the Ichimoku cloud · RSI 45 · MACD above its signal
None of the 29 investors followed here reported a position in VEXT.CN in their latest filing.
From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors
No member of Congress has disclosed a VEXT.CN trade since 2025.
From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
| Date | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Dec 30, 2025 | Phanos (Spiro Alexander)Director of Issuer | — | 1.33M | — |
| Dec 30, 2025 | Smith (Trevor)Senior Officer of Issuer | Disposition in the public market at price 0.18 per share. | 43K | $7.87K |
| Dec 29, 2025 | Smith (Trevor)Senior Officer of Issuer | Disposition in the public market at price 0.18 per share. | 194.7K | $35.63K |
| Dec 28, 2025 | Smith (Trevor)Senior Officer of Issuer | Disposition in the public market at price 0.20 per share. | 99.1K | $19.42K |
| Dec 25, 2025 | Smith (Trevor)Senior Officer of Issuer | Disposition in the public market at price 0.20 per share. | 32K | $6.40K |
| Dec 23, 2025 | Smith (Trevor)Senior Officer of Issuer | Disposition in the public market at price 0.20 per share. | 30K | $6.00K |
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 13.7 | -19.0 | 6.4 | 38.0 | -24.6 | -13.5 | 13.3 | 7.8 | -14.5 | 0.0 | −7.8% | ||
| 2025 | 3.0 | -11.8 | 20.0 | -25.0 | -14.8 | 43.5 | 27.3 | 31.0 | 32.7 | -23.3 | -10.7 | 2.0 | +54.5% |
| 2024 | 25.9 | -19.2 | -5.1 | 17.9 | -25.8 | -6.1 | 10.9 | -9.8 | 0.0 | -17.4 | 5.3 | -17.5 | −43.1% |
| 2023 | 4.2 | 16.0 | -10.3 | 13.5 | -8.5 | -3.7 | 0.0 | -3.8 | 38.0 | -14.5 | -10.2 | 9.4 | +20.8% |
| 2022 | -9.4 | 13.8 | -9.1 | -28.3 | 0.0 | -10.5 | 20.8 | -26.9 | -22.1 | 7.5 | -12.3 | -4.0 | −62.5% |
| 2021 | 24.2 | -17.1 | -12.7 | 12.4 | -11.0 | -15.7 | -2.7 | 5.5 | 2.6 | -5.1 | -5.3 | -9.9 | −35.4% |
| 2020 | 4.3 | -4.1 | -41.4 | 39.0 | -19.3 | 2.2 | 4.3 | -1.0 | -13.4 | -2.4 | 63.4 | 47.8 | +41.4% |
| 2019 | -3.7 | -10.3 | 7.3 | -53.7 | -20.7 | 18.5 | -9.1 | −63.4% |
Buy / hold / sell counts
Vext Science, Inc., through its subsidiaries, engages in integrated cannabis operations in the United States. It owns and manages cultivation facilities, manufacturing units, and dispensaries; and involves in the cultivation, extraction, manufacture, and sale of THC and CBD cartridges, concentrates, edibles, and extracts. The company also engages in the retail dispensary activities; and wholesale distribution of cannabis THC and hemp CBD products under the Vapen, Pure Touch, Appalachian Pharm, Herbal Wellness, Prism, Firebrand, and Revibe brands. The company was formerly known as Vapen MJ Ventures Corporation and changed its name to Vext Science, Inc. in November 2019. Vext Science, Inc. was incorporated in 2015 and is headquartered in Phoenix, Arizona.
No recent headlines.